Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
14 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PREGABALIN | 25MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162254 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162257 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162260 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2022-06-09 | 2023-06-09 | 162265 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2025-08-14 | 2025-09-04 | 265220 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2025-10-02 | 2025-11-27 | 268449 |
| TEVA-PREGABALIN | 300MG | CAPSULE | Resolved | 2025-10-02 | 2025-11-27 | 268452 |
| TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Resolved | 2019-07-02 | 2025-04-25 | 88222 |
| TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Resolved | 2019-07-02 | 2025-04-25 | 88225 |
| TEVA-PROFEN | 600MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42597 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2017-08-02 | 2017-10-10 | 17983 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-05-01 | 2020-06-04 | 113746 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-06-04 | 2020-06-25 | 116681 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-12-17 | 2021-02-11 | 130288 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-03-18 | 132633 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-05-20 | 2021-07-09 | 139740 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-06-24 | 2022-04-28 | 141480 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-09-02 | 2022-04-28 | 145127 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-30 | 190704 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Actual shortage | 2023-06-16 | 2025-10-14 | 195153 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |